SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001554795-21-000089
Filing Date
2021-03-25
Accepted
2021-03-25 16:11:44
Documents
39
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K cncl0323form10k.htm 10-K 325430
2 EXHIBIT 31.1 cncl0323form10kexh31_1.htm EX-31.1 8060
3 EXHIBIT 31.2 cncl0323form10kexh31_2.htm EX-31.2 8027
4 EXHIBIT 32.1 cncl0323form10kexh32_1.htm EX-32.1 4128
  Complete submission text file 0001554795-21-000089.txt   1165559

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cncl-20201231.xml EX-101.INS 87918
6 XBRL SCHEMA FILE cncl-20201231.xsd EX-101.SCH 13763
7 XBRL CALCULATION FILE cncl-20201231_cal.xml EX-101.CAL 25760
8 XBRL DEFINITION FILE cncl-20201231_def.xml EX-101.DEF 14646
9 XBRL LABEL FILE cncl-20201231_lab.xml EX-101.LAB 97637
10 XBRL PRESENTATION FILE cncl-20201231_pre.xml EX-101.PRE 75789
Mailing Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

IRS No.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-32363 | Film No.: 21772481
SIC: 6770 Blank Checks